This column is my opinion and expresses my views. Those views can change at a moments notice when the market changes. I am not right all the time and I do not expect to be. I disclose all my positions clearly listed on the page, and I do not trade my account on the stocks spoken of in this column unless fully disclosed. If that does not work for you stop reading and close the page. Do not bother me or harass me.
Otherwise, enjoy the column!
Subscribe to the Monster Stock Market Commentary and join the 1,956 subscribers getting it for FREE every day!
April 30, 2016
Michael Kramer and the clients of Mott Capital own ALphabet, NXPI
- S&P 500 Futures -1.5 points
- 10-Year Yields 2.53%
- Dollar Index 97.60
- Oil 64.12
- VIX 13.06
- China Shanghai +0.52%
- Hong Kong HSI -0.65%
- Japan Nikkei -0.22%
- South Kospi -0.58%
- Germany DAX -0.09%
- UK FTSE -0.22%
- China reported its manufacturing PMI for April at 50.2 versus March’s 50.8.
- We will get Chicago PMI at 9:45 this morning, expectations are for 59.1\
S&P 500 (SPY)
Stocks will attempt to set a record again today, but headwinds are bit stronger today, with Alphabet shares falling. The first level that may act as support is 2,940, the previous all-time high, and then it would be 2915. But again, there is no doubting that the overall trend is higher still. Additionally, weakness in Alphabet is likely to be offset by strong pharma results.
Alphabet (GOOGL, GOOG)
Alphabet shares are falling today after earnings, shocker! It seems to be what happens every quarter. The only part of the report I’m surprised about is that the stock broke out to an all-time high ahead of those results. The stock had been rising in a very well defined channel since December, up nearly 30% since the lows.
I think the results were fine, despite the company missing revenue estimates by less than 3% at $36.24 billion. The company continues to hire tons of employees, rising to nearly 104k from 85k. The tax rate also rose to 18% from 11%.
Hey, there big problem, trading! Get some new traders. Their equity portfolio saw gains of just $1.1 billion down from $3.0 billion last year, which lead to that decline of $1.5 billion in other income.
All of a sudden that EU fine, increased R&D, and poor Equity trading performance hurt the bottom line.
So, anyway… Support is around $1,200. As long as the stock closes above $1200, which I think it shall, the stock will remain in that long-term uptrend. And chalk the declines up to out of control expectations.
Hey NXPI is jumping today after it reported better than expected results, with revenue topping estimates, and earnings, that topped. Additionally, the company offered better than expected guidance. $106 is still the next level of resistance.
Intel will be on watch again as it continues its fall from its earnings release. $50.50 is a big level of support, and decline below that price sets up a drop to $49.
GE reported, and the stock is rising. $11 might a reasonable first stop. But looking at that cup-n-handle pattern one has to wonder if $12.30 is in play.
Merck and Pfizer are rising this morning after reporting better than expected results.
Merck has a resistance level at $79.15, and then again at $81.30
Pfizer’s next level of resistance doesn’t come until $42.25.
Don’t forget AMD and Apple tonight.
Good luck today!
Mott Capital Management, LLC is a registered investment adviser. Information presented is for educational purposes only and does not intend to make an offer or solicitation for the sale or purchase of any specific securities, investments, or investment strategies. Investments involve risk and unless otherwise stated, are not guaranteed. Be sure to first consult with a qualified financial adviser and/or tax professional before implementing any strategy discussed herein. Upon request, the advisor will provide a list of all recommendations made during the past twelve months. Past performance is not indicative of future results.